Private equity boosts pharma, biotech M&A

M&A activity in pharma and biotech markets picked up significantly during the first half of 2011, according to a recent report by HBM Partners. Transaction values from biopharma trade sales reached an impressive $51.6bn, compared to $67bn for the whole of last year.